Get the app!
Back to Trades

FRENKEL JACOB A

DirectorCIK 0001237418

Largest Purchase

No open-market purchases in the recent filings.

Profile

Filings
2
Buy transactions
0
Sell transactions
0
Companies
1
Active
2026

FRENKEL JACOB A, Director, has filed 2 SEC reports (2026), all concentrated in BRAINSTORM CELL THERAPEUTICS INC. (BCLI), totaling $0 in disclosed volume. Data is sourced from official SEC Form 3, 4, and 5 filings.

Trading History

2 loaded
Jul 28BCLI
BRAINSTORM CELL THERAPEUTICS INC.
FRENKEL JACOB ADirectorGrant$0
May 29BCLI
BRAINSTORM CELL THERAPEUTICS INC.
FRENKEL JACOB ADirectorGrant$0

2 filings